Global TB Deaths Drop 3% as Hope Rises

Global TB deaths fell 3% in 2024, marking the first decline since COVID-19. WHO says progress offers hope to end tuberculosis.
According to World Health Organization (WHO), deaths from TB dropped by three percent in 2024 compared to the previous year, while new cases fell by nearly two percent. The decline, though modest, showed a turning point after years of setbacks caused by pandemic-related disruptions.
An estimated 10.7 million people worldwide fell ill with TB in 2024: 5.8 million men, 3.7 million women and 1.2 million children.
A preventable and curable disease, tuberculosis is caused by bacteria that most often affects the lungs. It spreads through the air when people with TB cough, sneeze or spit.
Now, TB cases and deaths are both declining

“for the first time since the Covid-19 pandemic”,

which disrupted services, said Tereza Kasaeva, head of the WHO department for HIV, TB, hepatitis and sexually transmitted infections.

“Funding cuts and persistent drivers of the epidemic threaten to undo hard-won gains, but with political commitment, sustained investment, and global solidarity, we can turn the tide and end this ancient killer once and for all,” she said.

Advertisement

Funding for the fight against TB has stagnated since 2020.
Last year, $5.9 billion was available for prevention, diagnosis and treatment — way off the target of $22 billion annually by 2027.
Eight countries continue to bear the brunt of the global TB epidemic. Together, they account for nearly two-thirds of all cases worldwide:
  •  India (25%)
  •  Indonesia (10%)
  •  The Philippines (6.8%)
  •  China (6.5%)
  •  Pakistan (6.3%)
  •  Nigeria (4.8%)
  •  The Democratic Republic of Congo (3.9%)
  •  Bangladesh (3.6%)
The WHO also highlighted five major risk factors fueling the epidemic: undernutrition, HIV infection, diabetes, smoking, and alcohol use disorders.
TB remains the leading cause of death among people living with HIV, claiming 150,000 lives in 2024 alone.
Last year, treatment success rates rose from 68 percent to 71 percent.
The WHO estimates that timely TB treatment has saved 83 million lives since 2000.
 
Vaccine research, AI tools

“Declines in the global burden of TB, and progress in testing, treatment, social protection and research are all welcome news after years of setbacks, but progress is not victory,”

said WHO chief Tedros Adhanom Ghebreyesus.

“The fact that TB continues to claim over a million lives each year, despite being preventable and curable, is simply unconscionable.”

As for the pipeline of TB tests, treatments and vaccines, as of August this year, 63 diagnostic tests were in development and 29 drugs were in clinical trials.
Some 18 candidate vaccines are being tested on humans, including six in Phase III — the final stage before regulatory approval.
The BCG vaccine has long been part of routine childhood immunisation programmes in many countries.
But despite TB’s devastating global impact, no new vaccines have been licensed in over a century, and there are no vaccines for adults.
Peter Sands, head of the Global Fund to Fight AIDS, TB and Malaria, said:

“We now have shorter, more effective treatment regimens, improved prevention strategies, and cutting-edge diagnostics, including AI-powered tools that can detect TB faster and more accurately than ever before,” he said.

“These innovations are transforming how we fight TB, especially in resource-limited settings.”

Editorial Note

This report was produced by the editorial team at The Gazette News | Latest News In Nigeria & the World in line with our commitment to accuracy, fairness, and responsible journalism. Information in this article is based on verified sources available at the time of publication. The Gazette News | Latest News In Nigeria & the World may update the story as new facts emerge or additional context becomes available.

Independent Journalism
Our Independence Is Funded by You — Not Advertisers

The Gazette News | Latest News In Nigeria & the World accepts zero funding from governments, corporations, or political parties. No advertiser dictates our coverage. No political interest shapes our investigations. The journalism you just read exists because readers like you chose to protect it. Every contribution goes directly into the field — paying reporters, protecting sources, and ensuring the stories that matter get told without fear or favour.

34 Investigations
Funded by Readers
319+ Readers Supporting
Us Right Now
100% Independent
Share this story
✓ Link copied!
Add a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement